Kalaris Therapeutics, Inc. — All Filings
661 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-22-018805 | May 19, 2022 | May 17, 2022 |
| 8-K | 8-K | 0001193125-22-155023 | May 19, 2022 | May 17, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-018526 | May 18, 2022 | May 17, 2022 |
| 10-Q | 10-Q | 0000950170-22-007792 | May 5, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001193125-22-141341 | May 5, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015826 | Apr 28, 2022 | Apr 26, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015395 | Apr 22, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015394 | Apr 22, 2022 | Apr 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015393 | Apr 22, 2022 | Apr 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015392 | Apr 22, 2022 | Apr 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-015390 | Apr 22, 2022 | Apr 20, 2022 |
| DEFA14A | DEFA14A | 0001193125-22-097526 | Apr 6, 2022 | — |
| DEF 14A | DEF 14A | 0001193125-22-097515 | Apr 6, 2022 | May 17, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013339 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013338 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013336 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013334 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013332 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013331 | Apr 4, 2022 | Jan 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-012968 | Mar 31, 2022 | Mar 29, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-012967 | Mar 31, 2022 | Mar 29, 2022 |
| 8-K | 8-K | 0001193125-22-090667 | Mar 31, 2022 | Mar 29, 2022 |
| 10-K/A | 10-K/A | 0001193125-22-090062 | Mar 30, 2022 | Dec 31, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-010762 | Mar 11, 2022 | Mar 10, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-009059 | Mar 3, 2022 | Mar 2, 2022 |
| EFFECT | — | 9999999995-22-000522 | Feb 28, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-007029 | Feb 18, 2022 | Feb 16, 2022 |
| POS AM | POS AM | 0001193125-22-046631 | Feb 18, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005623 | Feb 10, 2022 | — |
| POS AM | POS AM | 0001193125-22-034613 | Feb 10, 2022 | — |
| S-8 | S-8 | 0001193125-22-034574 | Feb 10, 2022 | — |
| 10-K | 10-K | 0000950170-22-001075 | Feb 10, 2022 | Dec 31, 2021 |
| POSASR | POSASR (AMENDMENT NO. 1) | 0001193125-22-033661 | Feb 10, 2022 | — |
| 8-K | 8-K | 0001193125-22-033574 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000315066-22-000782 | Feb 9, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-003264 | Jan 26, 2022 | Jan 25, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-003144 | Jan 25, 2022 | Jan 24, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-003004 | Jan 24, 2022 | Jan 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-003003 | Jan 24, 2022 | Jan 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-003002 | Jan 24, 2022 | Jan 20, 2022 |
| 8-K | 8-K | 0001193125-22-005069 | Jan 10, 2022 | — |
| 8-K | 8-K | 0001193125-21-359961 | Dec 17, 2021 | Dec 16, 2021 |
| 8-K | 8-K | 0001193125-21-354690 | Dec 13, 2021 | Dec 11, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-046758 | Dec 3, 2021 | Dec 2, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-045272 | Nov 18, 2021 | Nov 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-044889 | Nov 16, 2021 | Nov 12, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-044619 | Nov 15, 2021 | Nov 10, 2021 |
| 8-K | 8-K | 0001193125-21-329021 | Nov 15, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-043670 | Nov 9, 2021 | Nov 5, 2021 |
| 10-Q | 10-Q | 0000950170-21-003160 | Nov 5, 2021 | Sep 30, 2021 |